CIK 0001607678 · Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461073877
- Phone
- 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- 8-K Event Regulation FD disclosure
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale President & CEO sold 26,889 shares at $27.80 ($747,633)
- 4 Open-market sale Chief Financial Officer sold 4,266 shares at $27.76 ($118,428)
- 4 Open-market sale Chief Operating Officer sold 4,266 shares at $27.77 ($118,473)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Shareholder vote results
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- DEFA14A Proxy Proxy Materials
- DEFR14A Other DEFR14A
- 8-K Event Results of operations
- 8-K Event Auditor change · Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- UPLOAD Other SEC-generated Letter
- 4 Option exercise Director acquired 20,786 shares (option exercise)
Page 4 of 33 · 652 filings